25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Analysis
Buy, Hold or Sell?

Let's analyze Telomir Pharmaceuticals, Inc. Common Stock together

I guess you are interested in Telomir Pharmaceuticals, Inc. Common Stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Telomir Pharmaceuticals, Inc. Common Stock’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Telomir Pharmaceuticals, Inc. Common Stock’s Price Targets

I'm going to help you getting a better view of Telomir Pharmaceuticals, Inc. Common Stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Telomir Pharmaceuticals, Inc. Common Stock

I send you an email if I find something interesting about Telomir Pharmaceuticals, Inc. Common Stock.

1. Quick Overview

1.1. Quick analysis of Telomir Pharmaceuticals, Inc. Common Stock (30 sec.)










1.2. What can you expect buying and holding a share of Telomir Pharmaceuticals, Inc. Common Stock? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.02
Expected worth in 1 year
$-0.07
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$-0.09
Return On Investment
-3.8%

For what price can you sell your share?

Current Price per Share
$2.49
Expected price per share
$2.48 - $3.75
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Telomir Pharmaceuticals, Inc. Common Stock (5 min.)




Live pricePrice per Share (EOD)
$2.49

2.2. Growth of Telomir Pharmaceuticals, Inc. Common Stock (5 min.)




Is Telomir Pharmaceuticals, Inc. Common Stock growing?

Current yearPrevious yearGrowGrow %
How rich?$643k$2.1m-$724.7k-51.1%

How much money is Telomir Pharmaceuticals, Inc. Common Stock making?

Current yearPrevious yearGrowGrow %
Making money-$4.1m-$3.2m-$880.2k-21.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Telomir Pharmaceuticals, Inc. Common Stock (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Telomir Pharmaceuticals, Inc. Common Stock?

Welcome investor! Telomir Pharmaceuticals, Inc. Common Stock's management wants to use your money to grow the business. In return you get a share of Telomir Pharmaceuticals, Inc. Common Stock.

First you should know what it really means to hold a share of Telomir Pharmaceuticals, Inc. Common Stock. And how you can make/lose money.

Speculation

The Price per Share of Telomir Pharmaceuticals, Inc. Common Stock is $2.49. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Telomir Pharmaceuticals, Inc. Common Stock.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Telomir Pharmaceuticals, Inc. Common Stock, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.02. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Telomir Pharmaceuticals, Inc. Common Stock.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-3.9%-0.14-5.6%-0.11-4.4%-0.11-4.5%-0.11-4.5%
Usd Book Value Change Per Share0.010.3%-0.02-0.9%0.041.5%0.000.1%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.3%-0.02-0.9%0.041.5%0.000.1%0.000.1%
Usd Price Per Share4.12-5.13-0.00-2.28-2.28-
Price to Earnings Ratio-10.58--12.34-0.00--5.49--5.49-
Price-to-Total Gains Ratio610.17--5.48--5.48--5.48-
Price to Book Ratio190.69-191.26-0.00-85.01-85.01-
Price-to-Total Gains Ratio610.17--5.48--5.48--5.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.49
Number of shares401
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (401 shares)-9.410.96
Gains per Year (401 shares)-37.663.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-38-4804-6
20-75-8608-2
30-113-1240122
40-151-1620156
50-188-20001910
60-226-23802314
70-264-27602718
80-301-31403122
90-339-35203526
100-377-39003930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.09.00.00.0%0.09.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.05.01.033.3%3.05.01.033.3%3.05.01.033.3%3.05.01.033.3%
Dividend per Share0.00.04.00.0%0.00.09.00.0%0.00.09.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share1.03.00.025.0%3.05.01.033.3%3.05.01.033.3%3.05.01.033.3%3.05.01.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Telomir Pharmaceuticals, Inc. Common Stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.007-0.023+448%0.037-82%0.002+181%0.002+181%
Book Value Per Share--0.0220.048-55%0.072-70%0.050-56%0.050-56%
Current Ratio--1.9443.704-48%0.112+1635%1.702+14%1.702+14%
Debt To Asset Ratio--0.5140.371+39%5.362-90%4.796-89%4.796-89%
Debt To Equity Ratio--1.0590.730+45%0.588+80%0.586+81%0.586+81%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--123207487.000153773189.000-20%--153773189.000-20%153773189.000-20%
Eps---0.097-0.139+43%-0.110+13%-0.113+16%-0.113+16%
Ev To Ebitda Ratio---10.627-15.977+50%---15.977+50%-15.977+50%
Ev To Sales Ratio--infinfnan%--infnan%infnan%
Free Cash Flow Per Share---0.020-0.043+109%-0.032+59%-0.034+68%-0.034+68%
Free Cash Flow To Equity Per Share--0.0140.011+36%0.000+100%0.005+208%0.005+208%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap74109123.000-65%122622324.000152533837.500-20%-+100%67792816.667+81%67792816.667+81%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio115.249-65%190.692191.2640%-+100%85.006+124%85.006+124%
Pe Ratio-6.392+40%-10.577-12.344+17%--100%-5.486-48%-5.486-48%
Price Per Share2.490-65%4.1205.125-20%-+100%2.278+81%2.278+81%
Price To Free Cash Flow Ratio-30.583+40%-50.603-35.380-30%--100%-15.724-69%-15.724-69%
Price To Total Gains Ratio368.770-65%610.174-5.482+101%---5.482+101%-5.482+101%
Quick Ratio--1.8593.559-48%0.037+4938%1.598+16%1.598+16%
Return On Assets---2.189-2.603+19%-3.112+42%-3.651+67%-3.651+67%
Return On Equity---4.507-5.264+17%-0.974-78%-2.773-38%-2.773-38%
Total Gains Per Share--0.007-0.023+448%0.037-82%0.002+181%0.002+181%
Usd Book Value--643037.0001417312.000-55%2142099.500-70%1477818.667-56%1477818.667-56%
Usd Book Value Change Per Share--0.007-0.023+448%0.037-82%0.002+181%0.002+181%
Usd Book Value Per Share--0.0220.048-55%0.072-70%0.050-56%0.050-56%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--123207487.000153773189.000-20%--153773189.000-20%153773189.000-20%
Usd Eps---0.097-0.139+43%-0.110+13%-0.113+16%-0.113+16%
Usd Free Cash Flow---605808.000-1267607.000+109%-964949.000+59%-1020668.333+68%-1020668.333+68%
Usd Free Cash Flow Per Share---0.020-0.043+109%-0.032+59%-0.034+68%-0.034+68%
Usd Free Cash Flow To Equity Per Share--0.0140.011+36%0.000+100%0.005+208%0.005+208%
Usd Market Cap74109123.000-65%122622324.000152533837.500-20%-+100%67792816.667+81%67792816.667+81%
Usd Price Per Share2.490-65%4.1205.125-20%-+100%2.278+81%2.278+81%
Usd Profit---2898373.000-4148179.000+43%-3267966.000+13%-3350186.222+16%-3350186.222+16%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.007-0.023+448%0.037-82%0.002+181%0.002+181%
 EOD+2 -6MRQTTM+19 -13YOY+17 -115Y+23 -910Y+23 -9

3.3 Fundamental Score

Let's check the fundamental score of Telomir Pharmaceuticals, Inc. Common Stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.392
Price to Book Ratio (EOD)Between0-1115.249
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.859
Current Ratio (MRQ)Greater than11.944
Debt to Asset Ratio (MRQ)Less than10.514
Debt to Equity Ratio (MRQ)Less than11.059
Return on Equity (MRQ)Greater than0.15-4.507
Return on Assets (MRQ)Greater than0.05-2.189
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Telomir Pharmaceuticals, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.949
Ma 20Greater thanMa 503.295
Ma 50Greater thanMa 1003.889
Ma 100Greater thanMa 2004.309
OpenGreater thanClose2.600
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Telomir Pharmaceuticals, Inc. Common Stock

Telomir Pharmaceuticals, Inc., a pre-clinical stage biopharmaceutical company, focuses on developing pharmaceutical products for reversal of oxidative stress, cellular protection, and regulatory mechanism. The company is developing Telomir 1, an oral small molecule metal ion regulator designed to extend telomere caps; maintain cellular balance; and combat oxidative stress that drives aging and disease progression. By modulating essential metal ions such as iron, and copper, Telomir-1 helps protect against age-related conditions, including Progeria, a rare genetic disorder that causes rapid aging in children; Wilson's disease, a genetic disorder leading to toxic copper buildup in the body; and Age-related Macular Degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer's disease. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Fundamental data was last updated by Penke on 2025-04-06 07:42:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Telomir Pharmaceuticals, Inc. Common Stock earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Telomir Pharmaceuticals, Inc. Common Stock to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--99.7%+99.7%
TTM--188.1%+188.1%
YOY--199.6%+199.6%
5Y--357.6%+357.6%
10Y--488.5%+488.5%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Telomir Pharmaceuticals, Inc. Common Stock is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Telomir Pharmaceuticals, Inc. Common Stock to theΒ Biotechnology industry mean.
  • -218.9% Return on Assets means thatΒ Telomir Pharmaceuticals, Inc. Common Stock generatedΒ $-2.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is -218.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -260.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-218.9%TTM-260.3%+41.4%
TTM-260.3%YOY-311.2%+50.9%
TTM-260.3%5Y-365.1%+104.7%
5Y-365.1%10Y-365.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-218.9%-12.3%-206.6%
TTM-260.3%-12.2%-248.1%
YOY-311.2%-12.0%-299.2%
5Y-365.1%-13.4%-351.7%
10Y-365.1%-15.3%-349.8%
4.3.1.3. Return on Equity

Shows how efficient Telomir Pharmaceuticals, Inc. Common Stock is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Telomir Pharmaceuticals, Inc. Common Stock to theΒ Biotechnology industry mean.
  • -450.7% Return on Equity means Telomir Pharmaceuticals, Inc. Common Stock generated $-4.51Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is -450.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -526.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-450.7%TTM-526.4%+75.7%
TTM-526.4%YOY-97.4%-429.0%
TTM-526.4%5Y-277.3%-249.2%
5Y-277.3%10Y-277.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-450.7%-16.1%-434.6%
TTM-526.4%-16.2%-510.2%
YOY-97.4%-15.8%-81.6%
5Y-277.3%-19.5%-257.8%
10Y-277.3%-21.7%-255.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Telomir Pharmaceuticals, Inc. Common Stock.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Telomir Pharmaceuticals, Inc. Common Stock is operatingΒ .

  • Measures how much profit Telomir Pharmaceuticals, Inc. Common Stock makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Telomir Pharmaceuticals, Inc. Common Stock to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--188.3%+188.3%
TTM--291.0%+291.0%
YOY--214.8%+214.8%
5Y--368.2%+368.2%
10Y--471.9%+471.9%
4.3.2.2. Operating Ratio

Measures how efficient Telomir Pharmaceuticals, Inc. Common Stock is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.233-2.233
TTM-3.152-3.152
YOY-3.084-3.084
5Y-5.091-5.091
10Y-6.520-6.520
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Telomir Pharmaceuticals, Inc. Common Stock.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Telomir Pharmaceuticals, Inc. Common Stock is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.94Β means the company has $1.94 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 1.944. The company is able to pay all its short-term debts. +1
  • The TTM is 3.704. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.944TTM3.704-1.760
TTM3.704YOY0.112+3.592
TTM3.7045Y1.702+2.002
5Y1.70210Y1.7020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9443.616-1.672
TTM3.7043.893-0.189
YOY0.1124.280-4.168
5Y1.7025.791-4.089
10Y1.7026.182-4.480
4.4.3.2. Quick Ratio

Measures if Telomir Pharmaceuticals, Inc. Common Stock is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Telomir Pharmaceuticals, Inc. Common Stock to theΒ Biotechnology industry mean.
  • A Quick Ratio of 1.86Β means the company can pay off $1.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 1.859. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.559. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.859TTM3.559-1.699
TTM3.559YOY0.037+3.522
TTM3.5595Y1.598+1.960
5Y1.59810Y1.5980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8592.920-1.061
TTM3.5593.417+0.142
YOY0.0374.170-4.133
5Y1.5985.727-4.129
10Y1.5986.469-4.871
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Telomir Pharmaceuticals, Inc. Common Stock.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Telomir Pharmaceuticals, Inc. Common StockΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Telomir Pharmaceuticals, Inc. Common Stock to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.51Β means that Telomir Pharmaceuticals, Inc. Common Stock assets areΒ financed with 51.4% credit (debt) and the remaining percentage (100% - 51.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 0.514. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.371. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.514TTM0.371+0.144
TTM0.371YOY5.362-4.991
TTM0.3715Y4.796-4.425
5Y4.79610Y4.7960.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5140.344+0.170
TTM0.3710.344+0.027
YOY5.3620.332+5.030
5Y4.7960.359+4.437
10Y4.7960.384+4.412
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Telomir Pharmaceuticals, Inc. Common Stock is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Telomir Pharmaceuticals, Inc. Common Stock to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 105.9% means that company has $1.06 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The MRQ is 1.059. The company is able to pay all its debts with equity. +1
  • The TTM is 0.730. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.059TTM0.730+0.329
TTM0.730YOY0.588+0.141
TTM0.7305Y0.586+0.144
5Y0.58610Y0.5860.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0590.407+0.652
TTM0.7300.427+0.303
YOY0.5880.402+0.186
5Y0.5860.448+0.138
10Y0.5860.493+0.093
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Telomir Pharmaceuticals, Inc. Common Stock generates.

  • Above 15 is considered overpriced butΒ always compareΒ Telomir Pharmaceuticals, Inc. Common Stock to theΒ Biotechnology industry mean.
  • A PE ratio of -10.58 means the investor is paying $-10.58Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The EOD is -6.392. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.577. Based on the earnings, the company is expensive. -2
  • The TTM is -12.344. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.392MRQ-10.577+4.185
MRQ-10.577TTM-12.344+1.767
TTM-12.344YOY--12.344
TTM-12.3445Y-5.486-6.858
5Y-5.48610Y-5.4860.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.392-1.809-4.583
MRQ-10.577-2.564-8.013
TTM-12.344-3.191-9.153
YOY--3.323+3.323
5Y-5.486-6.424+0.938
10Y-5.486-7.149+1.663
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The EOD is -30.583. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -50.603. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -35.380. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-30.583MRQ-50.603+20.020
MRQ-50.603TTM-35.380-15.223
TTM-35.380YOY--35.380
TTM-35.3805Y-15.724-19.655
5Y-15.72410Y-15.7240.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-30.583-2.461-28.122
MRQ-50.603-3.566-47.037
TTM-35.380-3.951-31.429
YOY--4.482+4.482
5Y-15.724-8.693-7.031
10Y-15.724-9.796-5.928
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Telomir Pharmaceuticals, Inc. Common Stock is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 190.69 means the investor is paying $190.69Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Telomir Pharmaceuticals, Inc. Common Stock:

  • The EOD is 115.249. Based on the equity, the company is expensive. -2
  • The MRQ is 190.692. Based on the equity, the company is expensive. -2
  • The TTM is 191.264. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD115.249MRQ190.692-75.444
MRQ190.692TTM191.264-0.572
TTM191.264YOY-+191.264
TTM191.2645Y85.006+106.258
5Y85.00610Y85.0060.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD115.2491.676+113.573
MRQ190.6922.283+188.409
TTM191.2642.457+188.807
YOY-2.507-2.507
5Y85.0063.773+81.233
10Y85.0064.321+80.685
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,324
Total Liabilities681
Total Stockholder Equity643
 As reported
Total Liabilities 681
Total Stockholder Equity+ 643
Total Assets = 1,324

Assets

Total Assets1,324
Total Current Assets1,324
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 1,266
Other Current Assets 58
Total Current Assets  (as reported)1,324
Total Current Assets  (calculated)1,324
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities681
Long-term Liabilities0
Total Stockholder Equity643
Total Current Liabilities
Accounts payable 588
Other Current Liabilities 93
Total Current Liabilities  (as reported)681
Total Current Liabilities  (calculated)681
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Retained Earnings -30,597
Other Stockholders Equity 31,240
Total Stockholder Equity (as reported)643
Total Stockholder Equity (calculated)643
+/-0
Other
Cash and Short Term Investments 1,266
Common Stock Shares Outstanding 29,575
Liabilities and Stockholders Equity 1,324
Net Debt -1,266
Net Invested Capital 643
Net Working Capital 643



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
0
0
0
49
0
5,922
5,319
4,774
3,503
2,102
1,042
1,324
1,3241,0422,1023,5034,7745,3195,922049000
   > Total Current Assets 
0
0
0
49
1
96
236
435
3,503
2,102
1,042
1,324
1,3241,0422,1023,50343523696149000
       Cash And Cash Equivalents 
0
0
0
1
-1
15
2
1
3,274
1,884
835
1,266
1,2668351,8843,2741215-11000
       Short-term Investments 
0
0
0
0
3
0
0
0
0
0
0
0
000000030000
       Net Receivables 
0
0
0
0
0
0
130
130
130
130
130
0
0130130130130130000000
       Other Current Assets 
0
0
0
47
0
81
1
304
99
88
77
58
58778899304181047000
   > Long-term Assets 
0
0
0
47
-1
5,826
5,082
4,339
0
0
0
0
00004,3395,0825,826-147000
> Total Liabilities 
0
0
0
986
0
2,033
3,141
1,336
487
534
600
681
6816005344871,3363,1412,0330986000
   > Total Current Liabilities 
0
0
0
986
0
2,033
3,141
1,336
487
534
600
681
6816005344871,3363,1412,0330986000
       Short-term Debt 
0
0
0
582
0
488
1,338
101
8
0
0
0
00081011,3384880582000
       Short Long Term Debt 
0
0
0
0
0
488
1,338
101
0
0
0
0
00001011,33848800000
       Accounts payable 
0
0
0
404
0
846
496
707
214
394
506
588
5885063942147074968460404000
       Other Current Liabilities 
0
0
0
582
0
699
811
527
273
140
93
93
93931402735278116990582000
   > Long-term Liabilities 000000000000
> Total Stockholder Equity
0
0
0
-937
-937
3,889
2,178
3,438
3,017
1,568
442
643
6434421,5683,0173,4382,1783,889-937-937000
   Common Stock000000000000
   Retained Earnings Total Equity000000000000
   Accumulated Other Comprehensive Income 0000000-9370000
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
55
0
6,915
6,915
17,502
23,335
23,335
28,141
31,240
31,24028,14123,33523,33517,5026,9156,915055000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-09-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-11,872
Operating Income-12,242-11,872
 
Operating Expense (+$)
Research Development2,235
Selling General Administrative9,636
Selling And Marketing Expenses0
Operating Expense11,87211,872
 
Net Interest Income (+$)
Interest Income48
Interest Expense--4,339
Other Finance Cost-8,677
Net Interest Income-4,291
 
Pretax Income (+$)
Operating Income-12,242
Net Interest Income-4,291
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,533-12,242
EBIT - interestExpense = 4,339
-33,065
-20,871
Interest Expense-4,339
Earnings Before Interest and Taxes (EBIT)0-20,871
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-16,533
Tax Provision-0
Net Income From Continuing Ops-16,533-16,533
Net Income-16,533
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net04,291
 

Technical Analysis of Telomir Pharmaceuticals, Inc. Common Stock
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Telomir Pharmaceuticals, Inc. Common Stock. The general trend of Telomir Pharmaceuticals, Inc. Common Stock is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Telomir Pharmaceuticals, Inc. Common Stock's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Telomir Pharmaceuticals, Inc. Common Stock Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Telomir Pharmaceuticals, Inc. Common Stock.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.11 < 3.198 < 3.75.

The bearish price targets are: 2.48.

Know someone who trades $TELO? Share this with them.πŸ‘‡

Telomir Pharmaceuticals, Inc. Common Stock Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Telomir Pharmaceuticals, Inc. Common Stock. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Telomir Pharmaceuticals, Inc. Common Stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Telomir Pharmaceuticals, Inc. Common Stock. The current macd is -0.43698709.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Telomir Pharmaceuticals, Inc. Common Stock price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Telomir Pharmaceuticals, Inc. Common Stock. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Telomir Pharmaceuticals, Inc. Common Stock price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Telomir Pharmaceuticals, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) ChartTelomir Pharmaceuticals, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Telomir Pharmaceuticals, Inc. Common Stock. The current adx is 35.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Telomir Pharmaceuticals, Inc. Common Stock shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Telomir Pharmaceuticals, Inc. Common Stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Telomir Pharmaceuticals, Inc. Common Stock. The current sar is 2.97.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Telomir Pharmaceuticals, Inc. Common Stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Telomir Pharmaceuticals, Inc. Common Stock. The current rsi is 33.95. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Telomir Pharmaceuticals, Inc. Common Stock Daily Relative Strength Index (RSI) ChartTelomir Pharmaceuticals, Inc. Common Stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Telomir Pharmaceuticals, Inc. Common Stock. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Telomir Pharmaceuticals, Inc. Common Stock price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Telomir Pharmaceuticals, Inc. Common Stock Daily Stochastic Oscillator ChartTelomir Pharmaceuticals, Inc. Common Stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Telomir Pharmaceuticals, Inc. Common Stock. The current cci is -81.8672446.

Telomir Pharmaceuticals, Inc. Common Stock Daily Commodity Channel Index (CCI) ChartTelomir Pharmaceuticals, Inc. Common Stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Telomir Pharmaceuticals, Inc. Common Stock. The current cmo is -37.23523208.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Telomir Pharmaceuticals, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) ChartTelomir Pharmaceuticals, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Telomir Pharmaceuticals, Inc. Common Stock. The current willr is -99.36748893.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Telomir Pharmaceuticals, Inc. Common Stock Daily Williams %R ChartTelomir Pharmaceuticals, Inc. Common Stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Telomir Pharmaceuticals, Inc. Common Stock.

Telomir Pharmaceuticals, Inc. Common Stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Telomir Pharmaceuticals, Inc. Common Stock. The current atr is 0.41309247.

Telomir Pharmaceuticals, Inc. Common Stock Daily Average True Range (ATR) ChartTelomir Pharmaceuticals, Inc. Common Stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Telomir Pharmaceuticals, Inc. Common Stock. The current obv is 629,565.

Telomir Pharmaceuticals, Inc. Common Stock Daily On-Balance Volume (OBV) ChartTelomir Pharmaceuticals, Inc. Common Stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Telomir Pharmaceuticals, Inc. Common Stock. The current mfi is 30.49.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Telomir Pharmaceuticals, Inc. Common Stock Daily Money Flow Index (MFI) ChartTelomir Pharmaceuticals, Inc. Common Stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Telomir Pharmaceuticals, Inc. Common Stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Telomir Pharmaceuticals, Inc. Common Stock Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Telomir Pharmaceuticals, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.949
Ma 20Greater thanMa 503.295
Ma 50Greater thanMa 1003.889
Ma 100Greater thanMa 2004.309
OpenGreater thanClose2.600
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Telomir Pharmaceuticals, Inc. Common Stock with someone you think should read this too:
  • Are you bullish or bearish on Telomir Pharmaceuticals, Inc. Common Stock? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Telomir Pharmaceuticals, Inc. Common Stock? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Telomir Pharmaceuticals, Inc. Common Stock

I send you an email if I find something interesting about Telomir Pharmaceuticals, Inc. Common Stock.


Comments

How you think about this?

Leave a comment

Stay informed about Telomir Pharmaceuticals, Inc. Common Stock.

Receive notifications about Telomir Pharmaceuticals, Inc. Common Stock in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.